NAGA

alpha-N-acetylgalactosaminidase, the group of Galactosidases alpha

Basic information

Region (hg38): 22:42058334-42070842

Links

ENSG00000198951NCBI:4668OMIM:104170HGNC:7631Uniprot:P17050AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • alpha-N-acetylgalactosaminidase deficiency type 2 (Definitive), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 1 (Strong), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 2 (Strong), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 1 (Supportive), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 2 (Supportive), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 3 (Supportive), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency type 1 (Strong), mode of inheritance: AR
  • alpha-N-acetylgalactosaminidase deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Kanzaki disease; Alpha-n-acetylgalactosaminidase deficiency; Schindler disease type I; Schindler disease type IIIARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Dermatologic; Neurologic2564952; 2243144; 7707696; 8071745; 8040340; 8782044; 11313741; 11251574; 14685826; 15619430

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NAGA gene.

  • Alpha-N-acetylgalactosaminidase_deficiency_type_1 (303 variants)
  • Inborn_genetic_diseases (43 variants)
  • Alpha-N-acetylgalactosaminidase_deficiency_type_2 (36 variants)
  • not_provided (35 variants)
  • not_specified (12 variants)
  • NAGA-related_disorder (7 variants)
  • Alpha-N-acetylgalactosaminidase_deficiency (6 variants)
  • Intellectual_disability (3 variants)
  • Alpha-N-acetylgalactosaminidase_deficiency_type_3 (2 variants)
  • Fetal_akinesia_deformation_sequence_1 (1 variants)
  • Arthrogryposis_multiplex_congenita (1 variants)
  • See_cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAGA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000262.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
115
clinvar
116
missense
1
clinvar
4
clinvar
87
clinvar
4
clinvar
1
clinvar
97
nonsense
14
clinvar
6
clinvar
1
clinvar
21
start loss
0
frameshift
10
clinvar
1
clinvar
2
clinvar
13
splice donor/acceptor (+/-2bp)
9
clinvar
9
Total 25 20 91 119 1

Highest pathogenic variant AF is 0.00364901

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NAGAprotein_codingprotein_codingENST00000396398 912489
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.77e-110.1161256990491257480.000195
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1692372440.9700.00001542723
Missense in Polyphen7076.9640.90952861
Synonymous0.9018495.20.8830.00000600785
Loss of Function0.5101820.50.8780.00000100210

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002970.000297
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001960.000193
Middle Eastern0.00005440.0000544
South Asian0.0004580.000457
Other0.0006530.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids. {ECO:0000269|PubMed:9741689}.;
Disease
DISEASE: Schindler disease (SCHIND) [MIM:609241]: Form of NAGA deficiency characterized by early-onset neuroaxonal dystrophy and neurological signs (convulsion during fever, epilepsy, psychomotor retardation and hypotonia). NAGA deficiency is typically classified in three main phenotypes: NAGA deficiency type I (Schindler disease or Schindler disease type I) with severe manifestations; NAGA deficiency type II (Kanzazi disease or Schindler disease type II) which is mild; NAGA deficiency type III (Schindler disease type III) characterized by mild-to-moderate neurologic manifestations. NAGA deficiency results in the increased urinary excretion of glycopeptides and oligosaccharides containing alpha-N-acetylgalactosaminyl moieties. Inheritance is autosomal recessive. {ECO:0000269|PubMed:2243144, ECO:0000269|PubMed:8782044}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Kanzaki disease (KANZD) [MIM:609242]: Autosomal recessive disorder characterized by late-onset, angiokeratoma corporis diffusum and mild intellectual impairment. {ECO:0000269|PubMed:11251574, ECO:0000269|PubMed:8040340}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human);Glycosphingolipid biosynthesis - globoseries (Consensus)

Recessive Scores

pRec
0.394

Intolerance Scores

loftool
0.257
rvis_EVS
-0.31
rvis_percentile_EVS
32.06

Haploinsufficiency Scores

pHI
0.338
hipred
N
hipred_score
0.219
ghis
0.559

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0945

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Naga
Phenotype
homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
oligosaccharide metabolic process;carbohydrate catabolic process;glycoside catabolic process;glycolipid catabolic process;glycosylceramide catabolic process
Cellular component
cytoplasm;lysosome;extracellular exosome
Molecular function
alpha-galactosidase activity;alpha-N-acetylgalactosaminidase activity;protein homodimerization activity